FdaApplication
ANDA 211091
Identifiers
- fda_app_no: ANDA211091
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2019-06-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SODIUM BICARBONATE | SODIUM BICARBONATE | 5MEQ/10ML (0.5MEQ/ML) | SOLUTION;INTRAVENOUS |
| SODIUM BICARBONATE | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION;INTRAVENOUS |
| SODIUM BICARBONATE | SODIUM BICARBONATE | 10MEQ/10ML (1MEQ/ML) | SOLUTION;INTRAVENOUS |
| SODIUM BICARBONATE | SODIUM BICARBONATE | 44.6MEQ/50ML (0.9MEQ/ML) | SOLUTION;INTRAVENOUS |
4 products